Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Shares Issued (2016 - 2025)

Palisade Bio (PALI) has disclosed Shares Issued for 14 consecutive years, with -$1000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to -$1000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.5 million, a 122.11% decrease, with the full-year FY2024 number at $2.5 million, down 9.14% from a year prior.
  • Shares Issued was -$1000.0 for Q3 2025 at Palisade Bio, down from $1000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $14.4 million in Q4 2022 to a low of -$7.7 million in Q3 2023.
  • A 4-year average of $1.6 million and a median of $1.6 million in 2022 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 207.04% in 2023; the steepest drop was 332.73% in 2023.
  • Palisade Bio's Shares Issued stood at $14.4 million in 2022, then crashed by 80.85% to $2.8 million in 2023, then plummeted by 154.17% to -$1.5 million in 2024, then soared by 99.93% to -$1000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Shares Issued are -$1000.0 (Q3 2025), $1000.0 (Q2 2025), and -$1.5 million (Q4 2024).